Building business partnerships in human and animal health

Parties with an interest to tackle major challenges related to infectious diseases in both humans and animals, in collaboration with appropriate business partners, turn to Immuno Valley. We effectively match business and science to specifically build, nurture, and support lasting business partnerships for R&D. Read more about How We Work>

Contact us

Interested in Immuno Valley Network or Services? 
Call us: +31 (0) 30 253 1142
Send an email:



  1. Bird flu confirmed in commercially-farmed birds in the Netherlands

    n the night of Friday 25 November 2016, Wageningen Bioveterinary Research (WBVR) confirmed an outbreak of H5 avian influenza (bird flu) on a duck farm in Biddinghuizen (municipality of Dronten). The birds on this farm, at three other locations belonging to the same concern in Hierden and one location in Ermelo, were humanely destroyed as a preventive measure. Some 180,000 ducks were culled. Read more...

  2. RIVM invests 2 million Euros for Vaccine Education

    The National Institute for Public Health and the Environment (RIVM) will invest 2 million Euros extra for extended conversations with parents about the vaccination program. The RIVM hopes to relieve the unrest about the vaccination among parents of young children. In the Netherlands, 9 in 10 children receive all vaccinations that are recommended by the government, this is the second year that a small decrease is seen in the vaccinations in newborns. Read more...

  3. Ludo Hellebrekers joins Immuno Valley Executive Board

    Ludo Hellebrekers has joined the Immuno Valley Executive Board. Ludo Hellebrekers is director of the Wageningen Bioveterinary Research Institute, in Lelystad. Read more...

More news


  1. Alternatives to Antibiotics (ATA)

    The objectives of the 2nd International Symposium are to highlight promising research results and novel technologies that provide alternatives to antibiotics for use in animal health and production, assess challenges associated with their commercialization and use, and provide actionable strategies to support their development. The symposium will focus on five product categories that could reduce the use of medically important antibiotics in animal health and production: 1) vaccines; 2) microbial-derived products; 3) phytochemicals; 4) immune-derived products; and 5) chemicals.

  2. Innnovation for Health

    Innovation for Health is the premier event on healthcare innovations in the Netherlands.

  3. Bio Europe Spring 2017

    The premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe's most innovative biopharma clusters.

  4. 4th Microbiome R&D and Business Collaboration Forum: Europe

    As part of its worldwide microbiome series, Global Engage is pleased to announce the Microbiome R&D and Business Collaboration Forum: Europe which will be held on 3 – 4 April, 2017.